Hidradenitis Suppurativa - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for
Hidradenitis Suppurativa (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
High burden of hospital resource utilization in patients with
hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics.
Diet In the prevention of
hidradenitis suppurativa (acne Inversa).
Absence of abnormal communication between the affected soft tissue planes and bowel segments is a key feature for differentiating
hidradenitis suppurativa from perianal fistulas (5, 8, 21).
Hidradenitis suppurativa. N Engl J Med 2012; 366: 158-64.
Hidradenitis suppurativa (HS) is a chronic inflammatory dermatosis characterized by recurring painful nodules and abscesses.
HIDRADENITIS SUPPURATIVA: AN UNDERDIAGNOSED SKIN PROBLEM OF WOMEN ROBERT L.
Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the apocrine glands, which mostly occurs in the axillar, inguinal, perianal, and perineal regions, as well as the inframammary fold and the intermammary cleft.
Hidradenitis suppurativa is a chronic and recurrent inflammation of the skin and subcutaneous tissue.
Hidradenitis Suppurativa (HS), also known as Verneuil's disease, fox den disease, pyoderma fistulans significa (PFS), or acne inversa, has now been increasingly recognised to be due to a chronic inflammatory recurring skin condition that involves the follicular occlusion of the folliculopilosebaceous units (FPSUs) [1].
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition primarily affecting the intertriginous skin of the axillary, inguinal, genital, and perianal areas of the body.
